|
End-of-day quote
Shenzhen S.E.
18/09/2026
|
5-day change | 1st Jan Change | ||
| 3.780 CNY | -0.53% |
|
-2.58% | -14.67% |
| 08-26 | Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 05-22 | Fuan Pharmaceutical Subsidiary Gets China Approval for Three Injectable Drugs | MT |
| Market Cap | 4.5B 672M 586M 553M 503M 939M 64.37B 944M 6.62B 2.56B 32.84B 2.52B 2.47B 105B | P/E 2024 |
18.6x | P/E 2025 | 73.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4.26B 636M 556M 524M 476M 890M 60.99B 894M 6.27B 2.42B 31.11B 2.39B 2.34B 99.8B | EV / Sales 2024 |
2.15x | EV / Sales 2025 | 2.9x |
| Free-Float |
68.44% | Yield 2024 |
1.12% | Yield 2025 | 1.58% |
| 1 day | -0.53% | ||
| 1 week | -2.58% | ||
| Current month | -4.55% | ||
| 1 month | -6.67% | ||
| 3 months | +7.08% | ||
| 6 months | -11.27% | ||
| Current year | -14.67% |
| 1 week | 3.71 |  | 3.87 |
| 1 month | 3.71 | | 4.2 |
| Current year | 3.24 | | 4.75 |
| 1 year | 3.24 | | 5 |
| 3 years | 2.92 | | 5.68 |
| 5 years | 2.92 | | 5.68 |
| 10 years | 2.87 | | 11.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lu Wang
CEO | Chief Executive Officer | 42 | 03/12/2023 |
Xue Song Yu
DFI | Director of Finance/CFO | 57 | 18/09/2009 |
Qin Tang
SEC | Corporate Secretary | 57 | 18/09/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Tian Xiang Wang
CHM | Chairman | 70 | 18/09/2009 |
Qin Tang
BRD | Director/Board Member | 57 | 18/09/2009 |
Xue Song Yu
BRD | Director/Board Member | 57 | 20/12/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 07/01/20 | Sell | Director | 3,000,000 | 0.3361% | ||
| 02/01/20 | Sell | Executive/Senior Manager | 30,300 | 0.0034% | ||
| 02/01/20 | Sell | Chief Financial Officer | 42,200 | 0.0047% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.53% | -2.58% | -18.18% | -11.68% | 674M | |
| -1.61% | -1.27% | +13.40% | +59.79% | 46.78B | |
| -1.02% | -3.01% | +36.66% | +100.50% | 37.88B | |
| +2.19% | +3.78% | +12.21% | +79.75% | 11.82B | |
| +1.32% | +1.54% | -10.59% | +12.87% | 11.61B | |
| -0.95% | -0.38% | +17.65% | +146.45% | 9.12B | |
| +0.39% | +2.72% | +29.99% | +39.46% | 7.38B | |
| +1.30% | +1.34% | +19.83% | +185.74% | 7.12B | |
| -0.06% | +1.94% | +39.71% | -18.67% | 7.21B | |
| +0.70% | -2.06% | -42.22% | +7.42% | 4.99B | |
| Average | +0.17% | +0.20% | +9.85% | +60.16% | 14.46B | |
| Weighted average by Cap. | -0.46% | -0.10% | +18.15% | +72.90% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.39B 357M 312M 294M 267M 499M 34.23B 502M 3.52B 1.36B 17.46B 1.34B 1.31B 56.01B | 1.74B 260M 227M 214M 194M 363M 24.88B 365M 2.56B 988M 12.69B 975M 953M 40.71B |
| Net income | 280M 41.79M 36.49M 34.43M 31.28M 58.44M 4.01B 58.71M 412M 159M 2.04B 157M 153M 6.55B | 77M 11.5M 10.04M 9.47M 8.61M 16.08M 1.1B 16.15M 113M 43.78M 562M 43.19M 42.23M 1.8B |
| Net Debt | -171M -25.47M -22.24M -20.98M -19.06M -35.61M -2.44B -35.78M -251M -96.97M -1.25B -95.65M -93.53M -3.99B | -236M -35.28M -30.8M -29.07M -26.41M -49.33M -3.38B -49.57M -348M -134M -1.73B -133M -130M -5.53B |
Employees
2,988
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | CN¥3.780 | -0.53% | 12,034,777 |
| 17/09/26 | CN¥3.800 | +0.80% | 8,010,425 |
| 16/09/26 | CN¥3.770 | +0.53% | 8,141,453 |
| 15/09/26 | CN¥3.750 | -2.85% | 12,394,800 |
| 14/09/26 | CN¥3.860 | +1.31% | 9,107,100 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300194 Stock
Select your edition
All financial news and data tailored to specific country editions
